Vespa crabro chromosome 18, iyVesCrab1.2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespa.
REFSEQ INFORMATION: The reference sequence is identical to\nOU342417.1.\nAssembly name: iyVesCrab1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/02/09. The original whole-genome shotgun project has the\naccession CAJUUB000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespa crabro Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC124430428, transcript variant X3
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC124430428, transcript variant X1
uncharacterized LOC124430428, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fatty acid synthase-like, transcript variant X2
fatty acid synthase-like, transcript variant X1
fatty acid synthase-like, transcript variant X4
fatty acid synthase-like, transcript variant X3
uncharacterized LOC124430430, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC124430430, transcript variant X1
uncharacterized LOC124430430, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 66% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 1 codon; substituted 3 bases at 3 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: fatty acid synthase-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 57% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC124430431, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC124430431, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
phospholipid scramblase 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phospholipid scramblase 2-like, transcript variant X1
phospholipid scramblase 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124430355, transcript variant X2
uncharacterized LOC124430355, transcript variant X1
uncharacterized protein LOC124430355 isoform X1
uncharacterized LOC124430355, transcript variant X3
uncharacterized protein LOC124430355 isoform X2
piggyBac transposable element-derived protein 4-like
uncharacterized LOC124430377, transcript variant X4
uncharacterized LOC124430377, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC124430377, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC124430377, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC124430377, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC124430377, transcript variant X1
uncharacterized LOC124430377, transcript variant X3
uncharacterized protein DDB_G0274353, transcript variant X5
uncharacterized protein DDB_G0274353, transcript variant X2
uncharacterized protein DDB_G0274353, transcript variant X3
uncharacterized protein DDB_G0274353, transcript variant X6
uncharacterized protein DDB_G0274353, transcript variant X1
uncharacterized protein DDB_G0274353 isoform X1
uncharacterized protein DDB_G0274353 isoform X2
uncharacterized protein DDB_G0274353, transcript variant X4
uncharacterized protein DDB_G0274353 isoform X3
uncharacterized protein DDB_G0274353 isoform X4
asparagine synthetase domain-containing protein CG17486, transcript variant X4
asparagine synthetase domain-containing protein CG17486, transcript variant X7
asparagine synthetase domain-containing protein CG17486, transcript variant X2
asparagine synthetase domain-containing protein CG17486, transcript variant X1
asparagine synthetase domain-containing protein CG17486, transcript variant X3
asparagine synthetase domain-containing protein CG17486, transcript variant X5
asparagine synthetase domain-containing protein CG17486, transcript variant X6
asparagine synthetase domain-containing protein CG17486 isoform X2
asparagine synthetase domain-containing protein CG17486 isoform X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC124430311, transcript variant X4
uncharacterized LOC124430311, transcript variant X3
uncharacterized LOC124430311, transcript variant X1
uncharacterized LOC124430311, transcript variant X2
uncharacterized LOC124430311, transcript variant X5
uncharacterized protein LOC124430311 isoform X4
uncharacterized protein LOC124430311 isoform X3
uncharacterized protein LOC124430311 isoform X2
uncharacterized protein LOC124430311 isoform X1
uncharacterized protein LOC124430311 isoform X5
CDK5 and ABL1 enzyme substrate 1, transcript variant X1
CDK5 and ABL1 enzyme substrate 1, transcript variant X2
CDK5 and ABL1 enzyme substrate 1 isoform X1
CDK5 and ABL1 enzyme substrate 1 isoform X2
radial spoke head 10 homolog B-like, transcript variant X2
radial spoke head 10 homolog B-like, transcript variant X1
radial spoke head 10 homolog B-like isoform X1
radial spoke head 10 homolog B-like isoform X2
radial spoke head 10 homolog B-like, transcript variant X3
radial spoke head 10 homolog B-like isoform X3
uncharacterized LOC124430335, transcript variant X2
uncharacterized protein LOC124430335 isoform X2
uncharacterized LOC124430335, transcript variant X3
uncharacterized LOC124430335, transcript variant X1
uncharacterized protein LOC124430335 isoform X1
uncharacterized protein LOC124430335 isoform X3
TM2 domain-containing protein CG10795, transcript variant X3
TM2 domain-containing protein CG10795, transcript variant X2
TM2 domain-containing protein CG10795, transcript variant X1
TM2 domain-containing protein CG10795 isoform X1
TM2 domain-containing protein CG10795 isoform X2
phosphatidylinositol N-acetylglucosaminyltransferase subunit A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
phosphatidylinositol N-acetylglucosaminyltransferase subunit A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphatidylinositol N-acetylglucosaminyltransferase subunit A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
phosphatidylinositol N-acetylglucosaminyltransferase subunit A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
phosphatidylinositol N-acetylglucosaminyltransferase subunit A, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
phosphatidylinositol N-acetylglucosaminyltransferase subunit A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphatidylinositol N-acetylglucosaminyltransferase subunit A, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
phosphatidylinositol N-acetylglucosaminyltransferase subunit A isoform X1
phosphatidylinositol N-acetylglucosaminyltransferase subunit A isoform X2
phosphatidylinositol N-acetylglucosaminyltransferase subunit A isoform X3
phosphatidylinositol N-acetylglucosaminyltransferase subunit A isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
histone-lysine N-methyltransferase SETMAR-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
uncharacterized LOC124430352, transcript variant X2
uncharacterized LOC124430352, transcript variant X3
uncharacterized LOC124430352, transcript variant X1
paired amphipathic helix protein Sin3a, transcript variant X7
paired amphipathic helix protein Sin3a, transcript variant X5
paired amphipathic helix protein Sin3a, transcript variant X9
paired amphipathic helix protein Sin3a, transcript variant X1
paired amphipathic helix protein Sin3a, transcript variant X6
paired amphipathic helix protein Sin3a, transcript variant X8
paired amphipathic helix protein Sin3a, transcript variant X2
paired amphipathic helix protein Sin3a, transcript variant X3
paired amphipathic helix protein Sin3a, transcript variant X4
paired amphipathic helix protein Sin3a isoform X4
paired amphipathic helix protein Sin3a isoform X5
paired amphipathic helix protein Sin3a isoform X3
paired amphipathic helix protein Sin3a isoform X2
paired amphipathic helix protein Sin3a isoform X6
paired amphipathic helix protein Sin3a isoform X1
paired amphipathic helix protein Sin3a, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
mitochondrial tRNA-specific 2-thiouridylase 1, transcript variant X1
mitochondrial tRNA-specific 2-thiouridylase 1, transcript variant X2
mitochondrial tRNA-specific 2-thiouridylase 1, transcript variant X3
mitochondrial tRNA-specific 2-thiouridylase 1, transcript variant X4
mitochondrial tRNA-specific 2-thiouridylase 1, transcript variant X5
mitochondrial tRNA-specific 2-thiouridylase 1 isoform X1
mitochondrial tRNA-specific 2-thiouridylase 1 isoform X2
mitochondrial tRNA-specific 2-thiouridylase 1 isoform X3
multiple epidermal growth factor-like domains protein 8, transcript variant X2
multiple epidermal growth factor-like domains protein 8, transcript variant X1
multiple epidermal growth factor-like domains protein 8, transcript variant X3
multiple epidermal growth factor-like domains protein 8, transcript variant X4
multiple epidermal growth factor-like domains protein 8, transcript variant X6
multiple epidermal growth factor-like domains protein 8, transcript variant X5
multiple epidermal growth factor-like domains protein 8, transcript variant X7
multiple epidermal growth factor-like domains protein 8 isoform X2
multiple epidermal growth factor-like domains protein 8 isoform X4
multiple epidermal growth factor-like domains protein 8 isoform X3
multiple epidermal growth factor-like domains protein 8 isoform X1
multiple epidermal growth factor-like domains protein 8 isoform X5
eukaryotic translation initiation factor 3 subunit K
GPI ethanolamine phosphate transferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
GPI ethanolamine phosphate transferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
GPI ethanolamine phosphate transferase 1 isoform X1
GPI ethanolamine phosphate transferase 1 isoform X2
splicing factor 3B subunit 2, transcript variant X2
splicing factor 3B subunit 2, transcript variant X1
splicing factor 3B subunit 2, transcript variant X3
crossover junction endonuclease MUS81, transcript variant X1
crossover junction endonuclease MUS81, transcript variant X2
crossover junction endonuclease MUS81 isoform X1
crossover junction endonuclease MUS81 isoform X2
triokinase/FMN cyclase-like, transcript variant X2
triokinase/FMN cyclase-like, transcript variant X1
triokinase/FMN cyclase-like, transcript variant X3
H(+)/Cl(-) exchange transporter 4, transcript variant X3
H(+)/Cl(-) exchange transporter 4, transcript variant X2
H(+)/Cl(-) exchange transporter 4, transcript variant X1
H(+)/Cl(-) exchange transporter 4 isoform X3
H(+)/Cl(-) exchange transporter 4 isoform X2
H(+)/Cl(-) exchange transporter 4 isoform X1
methylglutaconyl-CoA hydratase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
protein arginine N-methyltransferase 1, transcript variant X1
protein arginine N-methyltransferase 1, transcript variant X2
protein arginine N-methyltransferase 1, transcript variant X3
protein arginine N-methyltransferase 1 isoform X1
protein arginine N-methyltransferase 1 isoform X2
AT-rich interactive domain-containing protein 4B, transcript variant X3
AT-rich interactive domain-containing protein 4B, transcript variant X1
AT-rich interactive domain-containing protein 4B, transcript variant X2
AT-rich interactive domain-containing protein 4B isoform X1
AT-rich interactive domain-containing protein 4B isoform X2
ubiquitin carboxyl-terminal hydrolase 34
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ubiquitin carboxyl-terminal hydrolase 34
signal recognition particle 14 kDa protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
dnaJ homolog subfamily C member 10-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
dnaJ homolog subfamily C member 10-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
dnaJ homolog subfamily C member 10-like isoform X1
dnaJ homolog subfamily C member 10-like isoform X2
EH domain-containing protein 3, transcript variant X3
EH domain-containing protein 3, transcript variant X1
EH domain-containing protein 3, transcript variant X2
putative acid phosphatase 5, transcript variant X3
putative acid phosphatase 5, transcript variant X6
putative acid phosphatase 5, transcript variant X5
putative acid phosphatase 5, transcript variant X4
putative acid phosphatase 5, transcript variant X2
putative acid phosphatase 5, transcript variant X1
prostatic acid phosphatase-like isoform X1
transcription factor sem-2-like, transcript variant X1
transcription factor sem-2-like isoform X1
transcription factor sem-2-like, transcript variant X2
uncharacterized protein DDB_G0271670-like isoform X2
MAP/microtubule affinity-regulating kinase 3-like, transcript variant X3
MAP/microtubule affinity-regulating kinase 3-like isoform X2
MAP/microtubule affinity-regulating kinase 3-like, transcript variant X2
MAP/microtubule affinity-regulating kinase 3-like, transcript variant X1
MAP/microtubule affinity-regulating kinase 3-like, transcript variant X4
MAP/microtubule affinity-regulating kinase 3-like isoform X1
MAP/microtubule affinity-regulating kinase 3-like isoform X3
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1
E3 ubiquitin-protein ligase AMFR-like, transcript variant X3
E3 ubiquitin-protein ligase AMFR-like, transcript variant X2
E3 ubiquitin-protein ligase AMFR-like, transcript variant X1
hepatocyte nuclear factor 4-gamma, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
hepatocyte nuclear factor 4-gamma, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
hepatocyte nuclear factor 4-gamma, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
hepatocyte nuclear factor 4-gamma isoform X1
hepatocyte nuclear factor 4-gamma isoform X7
hepatocyte nuclear factor 4-gamma isoform X2
hepatocyte nuclear factor 4-gamma, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
hepatocyte nuclear factor 4-gamma isoform X4
hepatocyte nuclear factor 4-gamma, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
hepatocyte nuclear factor 4-gamma, transcript variant X5
hepatocyte nuclear factor 4-gamma isoform X5
hepatocyte nuclear factor 4-gamma, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
hepatocyte nuclear factor 4-gamma isoform X3
hepatocyte nuclear factor 4-gamma isoform X6
DNA replication complex GINS protein PSF3
guanine nucleotide-binding protein G(o) subunit alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
guanine nucleotide-binding protein G(o) subunit alpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
guanine nucleotide-binding protein G(o) subunit alpha
rRNA 2'-O-methyltransferase fibrillarin-like
ras-specific guanine nucleotide-releasing factor 2-like, transcript variant X3
ras-specific guanine nucleotide-releasing factor 2-like, transcript variant X1
ras-specific guanine nucleotide-releasing factor 2-like, transcript variant X4
ras-specific guanine nucleotide-releasing factor 2-like, transcript variant X2
ras-specific guanine nucleotide-releasing factor 2-like isoform X1
ras-specific guanine nucleotide-releasing factor 2-like isoform X3
ras-specific guanine nucleotide-releasing factor 2-like isoform X4
ras-specific guanine nucleotide-releasing factor 2-like isoform X2
uncharacterized LOC124430486, transcript variant X2
uncharacterized LOC124430486, transcript variant X1
hemicentin-1-like, transcript variant X2
hemicentin-1-like, transcript variant X3
hemicentin-1-like, transcript variant X1
uncharacterized LOC124430326, transcript variant X2
uncharacterized LOC124430326, transcript variant X1
uncharacterized protein LOC124430326 isoform X1
uncharacterized protein LOC124430326 isoform X2
facilitated trehalose transporter Tret1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein polybromo-1, transcript variant X1
protein polybromo-1, transcript variant X2
ER degradation-enhancing alpha-mannosidase-like protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ER degradation-enhancing alpha-mannosidase-like protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ER degradation-enhancing alpha-mannosidase-like protein 2, transcript variant X1
ER degradation-enhancing alpha-mannosidase-like protein 2
uncharacterized LOC124430508, transcript variant X1
uncharacterized LOC124430508, transcript variant X2
transcription initiation factor TFIID subunit 6-like, transcript variant X1
transcription initiation factor TFIID subunit 6-like, transcript variant X2
transcription initiation factor TFIID subunit 6-like isoform X1
transcription initiation factor TFIID subunit 6-like isoform X2
ubiquitin carboxyl-terminal hydrolase calypso, transcript variant X2
ubiquitin carboxyl-terminal hydrolase calypso, transcript variant X1
ubiquitin carboxyl-terminal hydrolase calypso isoform X1
ubiquitin carboxyl-terminal hydrolase calypso isoform X2
histone-lysine N-methyltransferase 2D-like, transcript variant X3
histone-lysine N-methyltransferase 2D-like, transcript variant X2
histone-lysine N-methyltransferase 2D-like, transcript variant X1
histone-lysine N-methyltransferase 2D-like isoform X2
transcription factor SPT20 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124430312, transcript variant X2
uncharacterized LOC124430312, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
glutaryl-CoA dehydrogenase, mitochondrial
one cut domain family member 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
one cut domain family member 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
one cut domain family member 2-like isoform X2
AT-rich interactive domain-containing protein 1B-like isoform X1
one cut domain family member 2-like, transcript variant X4
one cut domain family member 2-like, transcript variant X3
AT-rich interactive domain-containing protein 1B-like isoform X4
AT-rich interactive domain-containing protein 1B-like isoform X3
one cut domain family member 2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
AT-rich interactive domain-containing protein 1B-like isoform X5
uncharacterized LOC124430367, transcript variant X1
uncharacterized LOC124430367, transcript variant X2
uncharacterized protein LOC124430367 isoform X2
uncharacterized protein LOC124430367 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
poly(A) RNA polymerase gld-2 homolog A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
poly(A) RNA polymerase gld-2 homolog A-like, transcript variant X1
poly(A) RNA polymerase gld-2 homolog A-like, transcript variant X2
poly(A) RNA polymerase gld-2 homolog A-like isoform X1
poly(A) RNA polymerase gld-2 homolog A-like isoform X2
regulator of nonsense transcripts 1, transcript variant X1
regulator of nonsense transcripts 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
armadillo repeat-containing protein 3-like, transcript variant X2
armadillo repeat-containing protein 3-like, transcript variant X1
armadillo repeat-containing protein 3-like
armadillo repeat-containing protein 3, transcript variant X2
armadillo repeat-containing protein 3, transcript variant X1
armadillo repeat-containing protein 3 isoform X2
armadillo repeat-containing protein 3 isoform X1
uncharacterized protein DDB_G0271670, transcript variant X5
uncharacterized protein DDB_G0271670, transcript variant X6
uncharacterized protein DDB_G0271670, transcript variant X1
uncharacterized protein DDB_G0271670, transcript variant X4
uncharacterized protein DDB_G0271670, transcript variant X3
uncharacterized protein DDB_G0271670, transcript variant X2
collagen alpha-1(III) chain-like, transcript variant X6
collagen alpha-1(III) chain-like, transcript variant X4
glycine-rich protein DOT1-like isoform X4
glycine-rich protein DOT1-like isoform X2
collagen alpha-1(III) chain-like, transcript variant X5
collagen alpha-1(III) chain-like, transcript variant X1
collagen alpha-1(III) chain-like, transcript variant X2
collagen alpha-1(III) chain-like, transcript variant X3
glycine-rich protein DOT1-like isoform X3
collagen alpha-1(III) chain-like isoform X1
serine/threonine-protein kinase polo, transcript variant X1
serine/threonine-protein kinase polo isoform X1
serine/threonine-protein kinase polo, transcript variant X2
serine/threonine-protein kinase polo isoform X2
probable multidrug resistance-associated protein lethal(2)03659
dehydrogenase/reductase SDR family member 7, transcript variant X1
dehydrogenase/reductase SDR family member 7, transcript variant X3
dehydrogenase/reductase SDR family member 7, transcript variant X2
dehydrogenase/reductase SDR family member 7, transcript variant X4
dehydrogenase/reductase SDR family member 7
GTPase-activating protein skywalker, transcript variant X3
GTPase-activating protein skywalker, transcript variant X1
GTPase-activating protein skywalker, transcript variant X4
GTPase-activating protein skywalker, transcript variant X2
GTPase-activating protein skywalker, transcript variant X7
GTPase-activating protein skywalker, transcript variant X5
GTPase-activating protein skywalker, transcript variant X6
GTPase-activating protein skywalker isoform X4
GTPase-activating protein skywalker isoform X2
GTPase-activating protein skywalker isoform X3
GTPase-activating protein skywalker isoform X1
kynurenine 3-monooxygenase, transcript variant X4
kynurenine 3-monooxygenase, transcript variant X2
kynurenine 3-monooxygenase, transcript variant X1
kynurenine 3-monooxygenase, transcript variant X3
protein GDAP2 homolog, transcript variant X1
protein GDAP2 homolog, transcript variant X2
kinesin-related protein 4, transcript variant X1
kinesin-related protein 4, transcript variant X3
kinesin-related protein 4, transcript variant X2
kinesin-related protein 4, transcript variant X4
uncharacterized protein LOC124430350 isoform X1
uncharacterized protein LOC124430350 isoform X3
uncharacterized LOC124430289, transcript variant X1
uncharacterized LOC124430289, transcript variant X3
uncharacterized LOC124430289, transcript variant X2
uncharacterized protein LOC124430289 isoform X1
uncharacterized protein LOC124430289 isoform X3
uncharacterized protein LOC124430289 isoform X2
uncharacterized LOC124430291, transcript variant X2
uncharacterized LOC124430291, transcript variant X1
uncharacterized LOC124430290, transcript variant X3
uncharacterized LOC124430290, transcript variant X2
uncharacterized LOC124430290, transcript variant X1
glutamate synthase [NADH], transcript variant X2
glutamate synthase [NADH], transcript variant X3
glutamate synthase [NADH], transcript variant X1
glutamate synthase [NADH], transcript variant X4
glutamate synthase [NADH], transcript variant X5
glutamate synthase [NADH], transcript variant X6
general transcription factor II-I repeat domain-containing protein 2B-like
glycerophosphocholine phosphodiesterase GPCPD1, transcript variant X1
glycerophosphocholine phosphodiesterase GPCPD1, transcript variant X4
glycerophosphocholine phosphodiesterase GPCPD1, transcript variant X3
glycerophosphocholine phosphodiesterase GPCPD1, transcript variant X2
glycerophosphocholine phosphodiesterase GPCPD1 isoform X1
glycerophosphocholine phosphodiesterase GPCPD1 isoform X3
glycerophosphocholine phosphodiesterase GPCPD1 isoform X2
glycerophosphocholine phosphodiesterase GPCPD1 isoform X4
sodium/potassium-transporting ATPase subunit beta-2
intraflagellar transport protein 80 homolog, transcript variant X3
intraflagellar transport protein 80 homolog, transcript variant X1
intraflagellar transport protein 80 homolog, transcript variant X2
intraflagellar transport protein 80 homolog isoform X1
intraflagellar transport protein 80 homolog isoform X2
intraflagellar transport protein 80 homolog isoform X3
intraflagellar transport protein 80 homolog, transcript variant X4
intraflagellar transport protein 80 homolog, transcript variant X6
intraflagellar transport protein 80 homolog, transcript variant X5
intraflagellar transport protein 80 homolog, transcript variant X7
intraflagellar transport protein 80 homolog, transcript variant X8
intraflagellar transport protein 80 homolog isoform X5
intraflagellar transport protein 80 homolog isoform X4
intraflagellar transport protein 80 homolog isoform X6
sodium/potassium-transporting ATPase subunit beta-2-like, transcript variant X1
sodium/potassium-transporting ATPase subunit beta-2-like, transcript variant X2
sodium/potassium-transporting ATPase subunit beta-2-like, transcript variant X3
sodium/potassium-transporting ATPase subunit beta-2-like, transcript variant X4
sodium/potassium-transporting ATPase subunit beta-2-like
receptor-mediated endocytosis protein 6 homolog
amyloid protein-binding protein 2, transcript variant X3
amyloid protein-binding protein 2, transcript variant X2
amyloid protein-binding protein 2, transcript variant X1
amyloid protein-binding protein 2 isoform X2
amyloid protein-binding protein 2 isoform X1
amyloid protein-binding protein 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
eukaryotic initiation factor 4A-I, transcript variant X1
eukaryotic initiation factor 4A-I, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized protein LOC124430391 isoform X1
uncharacterized protein LOC124430391 isoform X2
proline-rich protein 7-like, transcript variant X2
proline-rich protein 7-like, transcript variant X1
transcriptional activator cubitus interruptus, transcript variant X2
transcriptional activator cubitus interruptus, transcript variant X1
transcriptional activator cubitus interruptus isoform X2
transcriptional activator cubitus interruptus isoform X1
transcriptional activator cubitus interruptus, transcript variant X3
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2
COP9 signalosome complex subunit 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
COP9 signalosome complex subunit 7, transcript variant X1
COP9 signalosome complex subunit 7, transcript variant X2
COP9 signalosome complex subunit 7 isoform X3
COP9 signalosome complex subunit 7 isoform X1
COP9 signalosome complex subunit 7 isoform X2
uncharacterized LOC124430299, transcript variant X2
uncharacterized LOC124430299, transcript variant X1
POU domain, class 6, transcription factor 1, transcript variant X4
POU domain, class 6, transcription factor 1, transcript variant X3
POU domain, class 6, transcription factor 1, transcript variant X2
POU domain, class 6, transcription factor 1, transcript variant X1
POU domain, class 6, transcription factor 1, transcript variant X6
POU domain, class 6, transcription factor 1 isoform X4
POU domain, class 6, transcription factor 1 isoform X3
POU domain, class 6, transcription factor 2 isoform X2
POU domain, class 6, transcription factor 2 isoform X1
POU domain, class 6, transcription factor 2 isoform X6
POU domain, class 6, transcription factor 1, transcript variant X7
POU domain, class 6, transcription factor 1, transcript variant X5
POU domain, class 6, transcription factor 1 isoform X7
POU domain, class 6, transcription factor 1 isoform X5
EF-hand calcium-binding domain-containing protein 1-like
uncharacterized LOC124430328, transcript variant X3
uncharacterized LOC124430328, transcript variant X1
uncharacterized LOC124430328, transcript variant X2
signal recognition particle receptor subunit beta
pyridoxine/pyridoxamine 5'-phosphate oxidase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
histidine protein methyltransferase 1 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ATP-dependent RNA helicase p62-like, transcript variant X1
ATP-dependent RNA helicase p62-like, transcript variant X2
ATP-dependent RNA helicase p62-like isoform X2
ATP-dependent RNA helicase p62-like isoform X1
ATP-dependent RNA helicase p62-like, transcript variant X3
mitochondrial thiamine pyrophosphate carrier
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X1
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X10
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X18
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X19
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X20
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X21
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X13
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X22
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X23
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X7
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X24
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X11
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X6
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X5
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X9
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X4
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X8
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X12
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X17
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X1
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X10
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X16
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X17
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X18
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X19
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X13
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X20
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X21
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X7
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X22
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X11
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X6
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X5
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X9
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X4
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X8
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X12
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X15
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X16
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X3
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X14
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X3
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X2
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X15
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X2
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X14
32 kDa beta-galactoside-binding lectin lec-3-like
serine palmitoyltransferase 2, transcript variant X1
serine palmitoyltransferase 2, transcript variant X2
stromal interaction molecule homolog, transcript variant X1
stromal interaction molecule homolog, transcript variant X2
stromal interaction molecule homolog isoform X1
stromal interaction molecule homolog isoform X2
ras-related protein Ral-a, transcript variant X4
ras-related protein Ral-a, transcript variant X1
ras-related protein Ral-a, transcript variant X2
ras-related protein Ral-a, transcript variant X7
ras-related protein Ral-a, transcript variant X6
ras-related protein Ral-a, transcript variant X3
ras-related protein Ral-a, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
protein O-mannosyl-transferase Tmtc3-like
U1 small nuclear ribonucleoprotein 70 kDa-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: U1 small nuclear ribonucleoprotein 70 kDa-like
potassium voltage-gated channel protein Shaker, transcript variant X10
potassium voltage-gated channel protein Shaker, transcript variant X9
potassium voltage-gated channel protein Shaker, transcript variant X5
potassium voltage-gated channel protein Shaker, transcript variant X7
potassium voltage-gated channel protein Shaker, transcript variant X8
potassium voltage-gated channel protein Shaker, transcript variant X6
potassium voltage-gated channel protein Shaker, transcript variant X4
potassium voltage-gated channel protein Shaker isoform X3
potassium voltage-gated channel protein Shaker, transcript variant X11
potassium voltage-gated channel protein Shaker, transcript variant X12
potassium voltage-gated channel protein Shaker isoform X4
potassium voltage-gated channel protein Shaker isoform X5
potassium voltage-gated channel protein Shaker, transcript variant X3
potassium voltage-gated channel protein Shaker, transcript variant X2
potassium voltage-gated channel protein Shaker, transcript variant X1
potassium voltage-gated channel protein Shaker isoform X2
potassium voltage-gated channel protein Shaker isoform X1
potassium voltage-gated channel protein Shaker, transcript variant X13
potassium voltage-gated channel protein Shaker, transcript variant X14
potassium voltage-gated channel protein Shaker isoform X6
potassium voltage-gated channel protein Shaker, transcript variant X15
potassium voltage-gated channel protein Shaker isoform X7
uncharacterized LOC124430412, transcript variant X2
uncharacterized LOC124430412, transcript variant X5
uncharacterized LOC124430412, transcript variant X3
uncharacterized LOC124430412, transcript variant X1
uncharacterized LOC124430412, transcript variant X4
uncharacterized protein LOC124430412 isoform X1
uncharacterized protein LOC124430412 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
leucine-rich repeat-containing protein 24-like, transcript variant X4
leucine-rich repeat-containing protein 24-like, transcript variant X3
leucine-rich repeat-containing protein 24-like, transcript variant X9
leucine-rich repeat-containing protein 24-like, transcript variant X2
leucine-rich repeat-containing protein 24-like, transcript variant X7
leucine-rich repeat-containing protein 24-like, transcript variant X8
leucine-rich repeat-containing protein 24-like, transcript variant X1
leucine-rich repeat-containing protein 24-like, transcript variant X5
leucine-rich repeat-containing protein 24-like, transcript variant X6
leucine-rich repeat-containing protein 24-like
succinate dehydrogenase assembly factor 3, mitochondrial
DC-STAMP domain-containing protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
unconventional myosin-Va, transcript variant X2
unconventional myosin-Va, transcript variant X1
unconventional myosin-Va, transcript variant X3
serine protease filzig, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
serine protease filzig, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serine proteinase stubble, transcript variant X1
serine proteinase stubble, transcript variant X2
uncharacterized LOC124430279, transcript variant X4
uncharacterized LOC124430279, transcript variant X3
uncharacterized LOC124430279, transcript variant X1
uncharacterized LOC124430279, transcript variant X2
F-box/LRR-repeat protein 20, transcript variant X2
F-box/LRR-repeat protein 20, transcript variant X1
F-box/LRR-repeat protein 20, transcript variant X3
pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins, and 42% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
biogenesis of lysosome-related organelles complex 1 subunit 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
biogenesis of lysosome-related organelles complex 1 subunit 1, transcript variant X1
biogenesis of lysosome-related organelles complex 1 subunit 1, transcript variant X3
biogenesis of lysosome-related organelles complex 1 subunit 1 isoform X1
biogenesis of lysosome-related organelles complex 1 subunit 1 isoform X2
ribonucleoside-diphosphate reductase large subunit-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16, transcript variant X1
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16, transcript variant X2
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16, transcript variant X3
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16, transcript variant X6
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16, transcript variant X5
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16, transcript variant X4
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 isoform X3
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 isoform X4
suppressor protein SRP40-like isoform X2
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 isoform X5
suppressor protein SRP40-like isoform X1
BMP and activin membrane-bound inhibitor homolog
CTD nuclear envelope phosphatase 1A, transcript variant X5
CTD nuclear envelope phosphatase 1A, transcript variant X1
CTD nuclear envelope phosphatase 1A, transcript variant X3
CTD nuclear envelope phosphatase 1A, transcript variant X4
CTD nuclear envelope phosphatase 1A, transcript variant X2
CTD nuclear envelope phosphatase 1 homolog isoform X1
CTD nuclear envelope phosphatase 1 homolog isoform X2
CTD nuclear envelope phosphatase 1 homolog isoform X4
CTD nuclear envelope phosphatase 1A isoform X3
F-box only protein 42, transcript variant X3
F-box only protein 42, transcript variant X2
F-box only protein 42, transcript variant X1
NPC intracellular cholesterol transporter 1 homolog 1b-like, transcript variant X2
NPC intracellular cholesterol transporter 1 homolog 1b-like, transcript variant X1
NPC intracellular cholesterol transporter 1 homolog 1b-like, transcript variant X3
NPC intracellular cholesterol transporter 1 homolog 1b-like isoform X2
NPC intracellular cholesterol transporter 1 homolog 1b-like isoform X1
NPC intracellular cholesterol transporter 1 homolog 1b-like isoform X3
NPC intracellular cholesterol transporter 1 homolog 1b-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
protein still life, isoforms C/SIF type 2, transcript variant X3
protein still life, isoforms C/SIF type 2, transcript variant X5
protein still life, isoforms C/SIF type 2, transcript variant X4
protein still life, isoforms C/SIF type 2, transcript variant X6
protein still life, isoforms C/SIF type 2, transcript variant X1
protein still life, isoforms C/SIF type 2, transcript variant X2
protein still life, isoforms C/SIF type 2, transcript variant X8
protein still life, isoforms C/SIF type 2, transcript variant X7
protein still life, isoform SIF type 1 isoform X2
protein still life, isoform SIF type 1 isoform X4
protein still life, isoform SIF type 1 isoform X3
protein still life, isoform SIF type 1 isoform X5
protein still life, isoform SIF type 1 isoform X1
protein still life, isoforms C/SIF type 2 isoform X7
protein still life, isoforms C/SIF type 2 isoform X6
reticulon-4-interacting protein 1, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase-like
probable N-acetyltransferase san, transcript variant X2
probable N-acetyltransferase san, transcript variant X3
probable N-acetyltransferase san isoform X3
probable N-acetyltransferase san, transcript variant X1
hormone-sensitive lipase, transcript variant X4
hormone-sensitive lipase, transcript variant X3
hormone-sensitive lipase, transcript variant X1
hormone-sensitive lipase, transcript variant X2
hormone-sensitive lipase, transcript variant X6
hormone-sensitive lipase, transcript variant X5
hormone-sensitive lipase, transcript variant X7
hormone-sensitive lipase, transcript variant X9
hormone-sensitive lipase, transcript variant X8
protein SYS1 homolog, transcript variant X1
protein SYS1 homolog, transcript variant X2
protein SYS1 homolog, transcript variant X3
NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial
PHD finger protein 20, transcript variant X1
PHD finger protein 20, transcript variant X6
PHD finger protein 20, transcript variant X2
PHD finger protein 20, transcript variant X3
PHD finger protein 20, transcript variant X4
PHD finger protein 20, transcript variant X5
uncharacterized protein LOC124430478 isoform X1
uncharacterized protein LOC124430478 isoform X6
uncharacterized protein LOC124430478 isoform X2
uncharacterized protein LOC124430478 isoform X5
PHD finger protein 20, transcript variant X7
uncharacterized protein LOC124430478 isoform X7
serine/threonine-protein kinase mig-15, transcript variant X2
serine/threonine-protein kinase mig-15, transcript variant X4
serine/threonine-protein kinase mig-15, transcript variant X5
serine/threonine-protein kinase mig-15, transcript variant X7
serine/threonine-protein kinase mig-15, transcript variant X8
serine/threonine-protein kinase mig-15, transcript variant X1
serine/threonine-protein kinase mig-15, transcript variant X3
serine/threonine-protein kinase mig-15, transcript variant X15
serine/threonine-protein kinase mig-15, transcript variant X14
serine/threonine-protein kinase mig-15, transcript variant X6
serine/threonine-protein kinase mig-15, transcript variant X9
serine/threonine-protein kinase mig-15, transcript variant X10
serine/threonine-protein kinase mig-15, transcript variant X11
serine/threonine-protein kinase mig-15, transcript variant X12
serine/threonine-protein kinase mig-15, transcript variant X18
serine/threonine-protein kinase mig-15, transcript variant X17
serine/threonine-protein kinase mig-15, transcript variant X19
serine/threonine-protein kinase mig-15 isoform X1
serine/threonine-protein kinase mig-15 isoform X6
serine/threonine-protein kinase mig-15 isoform X9
serine/threonine-protein kinase mig-15 isoform X11
serine/threonine-protein kinase mig-15 isoform X17
serine/threonine-protein kinase mig-15 isoform X19
serine/threonine-protein kinase mig-15 isoform X2
serine/threonine-protein kinase mig-15 isoform X10
serine/threonine-protein kinase mig-15 isoform X12
serine/threonine-protein kinase mig-15 isoform X18
serine/threonine-protein kinase mig-15 isoform X4
serine/threonine-protein kinase mig-15 isoform X5
serine/threonine-protein kinase mig-15 isoform X7
serine/threonine-protein kinase mig-15 isoform X3
serine/threonine-protein kinase mig-15 isoform X8
serine/threonine-protein kinase mig-15 isoform X14
serine/threonine-protein kinase mig-15 isoform X15
serine/threonine-protein kinase mig-15, transcript variant X13
serine/threonine-protein kinase mig-15, transcript variant X16
serine/threonine-protein kinase mig-15 isoform X13
serine/threonine-protein kinase mig-15 isoform X16
protein downstream neighbor of son homolog
zinc finger and BTB domain-containing protein 14-like, transcript variant X1
zinc finger and BTB domain-containing protein 14-like, transcript variant X12
zinc finger and BTB domain-containing protein 14-like isoform X1
zinc finger and BTB domain-containing protein 14-like isoform X4
zinc finger and BTB domain-containing protein 14-like, transcript variant X3
zinc finger and BTB domain-containing protein 14-like, transcript variant X5
zinc finger and BTB domain-containing protein 14-like, transcript variant X6
zinc finger and BTB domain-containing protein 14-like, transcript variant X2
zinc finger and BTB domain-containing protein 14-like, transcript variant X7
zinc finger and BTB domain-containing protein 14-like, transcript variant X8
zinc finger and BTB domain-containing protein 14-like, transcript variant X9
zinc finger and BTB domain-containing protein 14-like, transcript variant X10
zinc finger and BTB domain-containing protein 14-like, transcript variant X4
zinc finger and BTB domain-containing protein 14-like isoform X2
zinc finger and BTB domain-containing protein 14-like, transcript variant X11
zinc finger and BTB domain-containing protein 14-like isoform X3
zinc finger and BTB domain-containing protein 14-like, transcript variant X13
zinc finger and SCAN domain-containing protein 5B-like isoform X5
gamma-aminobutyric acid receptor subunit beta, transcript variant X1
gamma-aminobutyric acid receptor subunit beta, transcript variant X10
gamma-aminobutyric acid receptor subunit beta, transcript variant X8
gamma-aminobutyric acid receptor subunit beta, transcript variant X6
gamma-aminobutyric acid receptor subunit beta, transcript variant X2
gamma-aminobutyric acid receptor subunit beta, transcript variant X9
gamma-aminobutyric acid receptor subunit beta, transcript variant X7
gamma-aminobutyric acid receptor subunit beta, transcript variant X5
gamma-aminobutyric acid receptor subunit beta, transcript variant X11
gamma-aminobutyric acid receptor subunit beta, transcript variant X4
gamma-aminobutyric acid receptor subunit beta, transcript variant X3
gamma-aminobutyric acid receptor subunit beta isoform X10
gamma-aminobutyric acid receptor subunit beta isoform X8
gamma-aminobutyric acid receptor subunit beta isoform X6
gamma-aminobutyric acid receptor subunit beta isoform X2
gamma-aminobutyric acid receptor subunit beta isoform X9
gamma-aminobutyric acid receptor subunit beta isoform X7
gamma-aminobutyric acid receptor subunit beta isoform X5
gamma-aminobutyric acid receptor subunit beta isoform X11
gamma-aminobutyric acid receptor subunit beta isoform X4
gamma-aminobutyric acid receptor subunit beta isoform X3
gamma-aminobutyric acid receptor subunit beta isoform X1
glutamate receptor 1, transcript variant X1
glutamate receptor 1, transcript variant X2
glutamate receptor 1, transcript variant X3
glutamate receptor 1, transcript variant X5
glutamate receptor 1, transcript variant X7
glutamate receptor 1, transcript variant X6
glutamate receptor 1, transcript variant X4
uncharacterized LOC124430317, transcript variant X3
uncharacterized LOC124430317, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC124430317, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
general transcription factor IIE subunit 2, transcript variant X3
general transcription factor IIE subunit 2, transcript variant X2
general transcription factor IIE subunit 2, transcript variant X1
general transcription factor IIE subunit 2
ras-related and estrogen-regulated growth inhibitor, transcript variant X4
ras-related and estrogen-regulated growth inhibitor, transcript variant X1
ras-related and estrogen-regulated growth inhibitor, transcript variant X3
ras-related and estrogen-regulated growth inhibitor, transcript variant X5
ras-related and estrogen-regulated growth inhibitor, transcript variant X2
ras-related and estrogen-regulated growth inhibitor isoform X1
ras-related and estrogen-regulated growth inhibitor isoform X2
uncharacterized LOC124430319, transcript variant X2
uncharacterized LOC124430319, transcript variant X1
uncharacterized protein LOC124430319 isoform X2
uncharacterized protein LOC124430319 isoform X1
tyrosine 3-monooxygenase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
tyrosine 3-monooxygenase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC124430305, transcript variant X3
uncharacterized LOC124430305, transcript variant X1
uncharacterized LOC124430305, transcript variant X2
uncharacterized protein LOC124430305 isoform X1
uncharacterized protein LOC124430305 isoform X2
probable G-protein coupled receptor CG31760, transcript variant X4
probable G-protein coupled receptor CG31760, transcript variant X2
probable G-protein coupled receptor CG31760, transcript variant X1
probable G-protein coupled receptor CG31760, transcript variant X6
probable G-protein coupled receptor CG31760, transcript variant X5
probable G-protein coupled receptor CG31760, transcript variant X3
probable G-protein coupled receptor CG31760 isoform X3
probable G-protein coupled receptor CG31760 isoform X2
probable G-protein coupled receptor CG31760 isoform X1
probable G-protein coupled receptor CG31760, transcript variant X7
probable G-protein coupled receptor CG31760 isoform X4
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11, transcript variant X6
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11, transcript variant X5
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11, transcript variant X4
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11, transcript variant X1
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11, transcript variant X3
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11, transcript variant X2
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11, transcript variant X7
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 isoform X4
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 isoform X1
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 isoform X3
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 isoform X2
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 isoform X5
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11, transcript variant X8